Sanofi: stock up, with FX gains in Q3

(CercleFinance.com) - Sanofi said on Wednesday it expects to book a positive currency effect in its Q3 results following the recent depreciation of the euro.


Up about 1.5%, the stock was the biggest (and almost the only) winner in the pan-European Euro STOXX 50 index today.

In a morning statement, the French biopharmaceutical group said it expected a favourable impact of around 10% to 11% on its quarterly sales and 12% to 13% on its EPS.

The company points out that the European currency was worth $1.01 last week, compared with $1.18 in September 2021, a decline of over 14%.

The euro's slide towards the symbolic threshold of parity with the dollar should provide a big boost to European exporting companies, which invoice a large part of their sales in dollars but whose costs are denominated in euros.

Sanofi is set to publish its Q3 results on 28 October.



Copyright (c) 2022 CercleFinance.com. All rights reserved.